A new orally active antidiabetic vanadyl complex -: bis(α-furancarboxylato)oxovanadium(IV)

被引：46

作者：

Xie, MJ ^{[1
]}

Gao, LH

Ling, L

Liu, WP

Yan, SP

机构：

[1] Nankai Univ, Dept Chem, Tianjin 300071, Peoples R China

[2] Kunming Med Coll, Yunnan Pharmacol Labs Nat Prod, Kunming 650031, Peoples R China

[3] Kunming Inst Precious Met, Kunming 650221, Peoples R China

来源：

JOURNAL OF INORGANIC BIOCHEMISTRY | 2005年 / 99卷 / 02期

基金：

中国国家自然科学基金;

关键词：

oxovanadium; alpha-furancarboxylic acid; insulinomimetic activity;

D O I：

10.1016/j.jinorgbio.2004.10.033

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Bis(alpha-furanearboxylato)oxovanadium(IV) - a new orally active antidiabetic vanadyl complex has been synthesized, characterized, and tested for bioactivity as insulin-enhancing agents. The complex was administered intragastrically to both normal and STZ-diabetic rats for 4 weeks. The results show that the complex at a dose of 10.0 and 20.0 mg V kg(-1), could significantly lower the blood glucose level rats and ameliorated impaired glucose tolerance in STZ-diabetic, but not in normal rats. It was suggested that the complex exerted an antidiabetic effect in STZ-diabetic rats, which maybe was related to increasing the sensitivity to insulin. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：546 / 551

页数：6

共 50 条

[31] A TETRANUCLEAR VANADIUM(III, III, IV, IV) COMPLEX FORMED BY A REACTION OF BIS(ACETYLACETONATO)OXOVANADIUM(IV) WITH A THIOLATE LIGAND
MIKURIYA, M
KOTERA, T
ADACHI, F
BANDOW, S
CHEMISTRY LETTERS, 1993, (06) : 945 - 948
[32] Development of nanofunctionalized oxovanadium(IV) complex and its anticancer, antidiabetic, DNA cleavage and cell imaging studies
Sunitha, N.
Raj, C. Isac Sobana
Kumari, B. Sindhu
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 644
[33] Eco-Friendly Synthesis of an Oxovanadium(IV)-bis(abietate) Complex with Antimicrobial Action
Schons, Aline B.
Correa, Jamille S.
Appelt, Patricia
Meneguzzi, Daiane
Cunha, Mario A. A.
Bittencourt, Carla
Toma, Henrique E.
Anaissi, Fauze J.
MOLECULES, 2022, 27 (19):
[34] Synthesis, structural characterization, DFT studies and in-vitro antidiabetic activity of new mixed ligand oxovanadium(IV) complex with tridentate Schiff base
Patel, R. N.
Singh, Yogendra Pratap
JOURNAL OF MOLECULAR STRUCTURE, 2018, 1153 : 162 - 169
[35] A new biomimetic model for the active site of oxovanadium(IV)-transferrins -: [OVIV (tf)]
Neves, A
Romanowski, SMD
Vencato, I
Mangrich, AS
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 1998, 9 (05) : 426 - 429
[36] Effects of bis(maltolato)oxovanadium(IV) on insulin receptor localization and compartmentalization in membrane microdomains: Modes of action for an antidiabetic vanadium compound
Winter, Peter W.
Al-Qatati, Abeer
Wolf-Ringwall, Amber L.
Schoeberl, Samantha
Chatterjee, Pabitra B.
Barisas, George
Roess, Deborah A.
Crans, Debbie C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[37] BIS(ACETATO)AMMINEDICHLORO(CYCLOHEXYLAMINE)PLATINUM(IV), AN ORALLY-ACTIVE ANTICANCER DRUG
NEIDLE, S
SNOOK, CF
MURRER, BA
BARNARD, CFJ
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1995, 51 : 822 - 824
[38] SYNTHESIS AND CHARACTERIZATION OF A NEW COMPLEX OF OXOVANADIUM (IV) WITH NARINGENIN, AS POTENTIAL INSULINOMIMETIC AGENT
Uivarosi, Valentina
Badea, Mihaela
Olar, Rodica
Velescu, Bruno Stefan
Alder, Victoria
FARMACIA, 2016, 64 (02) : 175 - 180
[39] Antidiabetic activity of the orally effective vanadyl-poly (γ-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice
Karmaker, Subarna
Sahai, Tapan Kumar
Sakura, Hiromu
JOURNAL OF BIOMATERIALS APPLICATIONS, 2008, 22 (05) : 449 - 464
[40] A vanadyl Schiff base complex: {2,2′-[1,1′-(o-phenylenedinitrilo)bis(ethan-1-yl-1-ylidene)]diphenolato}oxovanadium(IV)
Kurzak, Krzysztof
Ejsmont, Krzysztof
Koprek, Katarzyna
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2011, 67 : M287 - M289

← 1 2 3 4 5 →